Founder and Managing Director
Univ. Prof. Dr. Krishnaraj Rajalingam is one of the highly recognized experts in the field of molecular signaling pathways. As head of the Department of Cell Biology (CBU) at the University Medical Center Mainz, he has numerous research successes to his credit. In addition to his leadership role at CBU, he is a member of the Research Center for Immunotherapy (FZI) and the University Center for Tumor Diseases (UCT) at the University Medical Center Mainz. His research into cell signaling pathways provide the foundation for developing novel therapeutics.
Prof. Dr. med. Hartmut Juhl is an entrepreneur, surgical oncologist, and world-renowned researcher dedicated to the science of tissue quality and its application to precision medicine in cancer diagnostics and therapeutics. The CEO and founder of Indivumed established the company to decipher the complexity of cancer and to advance personalized oncology and has received several awards of recognition for his visionary entrepreneurial spirit. In addition to Indivumed’s invaluable capabilities, Hartmut also contributes his decades of experience in building businesses to KHR Biotec.
Lab Team Leader
Dr. Hajime Yurugi is the research lab team leader. Trained as a molecular cell biologist addressing pertinent questions in tumor biology and immunology, Hajime brings his rich experience in wet lab biology to KHR Biotec and aims to build a strong team to perform cutting-edge research with clear and explicit biomedical implications.
We are further supported and advised by a seasoned team of interdisciplinary experts who serve as advisors and consultants. More updates will be announced soon.